The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index

The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index

Abstract Background In this non-interventional study, the functionality and well-being of patients with schizophrenia with aripiprazole once-monthly (AOM) was evaluated under real-life conditions in a naturalistic population. Methods This non-interventional, prospective, multicenter 6-month study in...

Full description

Bibliographic Details
Main Authors: Daniel Schöttle, Wolfgang Janetzky, Daniel Luedecke, Elmar Beck, Christoph U. Correll, Klaus Wiedemann
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Psychiatry
Subjects:
Long-acting injectable
LAI
Naturalistic
Schizophrenia
Schizoaffective
Patient perspective
Online Access:http://link.springer.com/article/10.1186/s12888-020-02488-1

Internet

http://link.springer.com/article/10.1186/s12888-020-02488-1

Similar Items